Literature DB >> 25824438

Cytomegalovirus-associated biliary atresia: An aetiological and prognostic subgroup.

Augusto Zani1, Alberto Quaglia2, Nedim Hadzić3, Mark Zuckerman4, Mark Davenport5.   

Abstract

BACKGROUND AND AIMS: Perinatal cytomegalovirus (CMV) infection is a possible cause or trigger of biliary atresia though clinical evidence is scant. We hypothesised that CMV IgM+ve biliary atresia is a separate clinical entity compared to CMV IgM-ve biliary atresia.
METHODS: Prospective single-centre study. 210 infants with histologically confirmed biliary atresia were treated in our institution (Jan. 2004 to Dec. 2011); of these 20 (9.5%) were CMV IgM+ve at presentation. We compared these with 111 infants who were CMV IgM-ve (controls) for clinical features, biochemistry at presentation and outcome following Kasai portoenterostomy (KPE). A blinded comparison of age-matched liver histology was also performed. Data are quoted as median (interquartile range). A P value ≤ 0.05 was regarded as significant.
RESULTS: Infants with CMV IgM+ve biliary atresia were older at Kasai portoenterostomy (or laparotomy) [70 (60-80) days vs. 56 (44-75)days; P = 0.003] and were more jaundiced [175 (147-224) vs. 140 (121-181) μmol/L; P = 0.002+ with higher AST*287 (157-403) vs. 180 (133-254) IU/L; P = 0.005] and aspartate aminotransferase-to-platelet ratio index [1.1 (0.79-3.0) vs. 0.63 (0.43-0.95)] levels. Liver histology: CMV IgM+ve biliary atresia was characterised by a greater degree of inflammation (P < 0.0001) and fibrosis (P = 0.02), whereas CMV IgM-ve isolated biliary atresia had a higher degree of lobular cholestasis (P = 0.001). This effect was independent of the effects of age at KPE. OUTCOME: CMV IgM+ve biliary atresia had a poorer outcome with a reduced clearance of jaundice (15% vs. 52.2%; P = 0.002), native liver survival (P < 0.0001) and increased mortality (P = 0.002).
CONCLUSIONS: CMV IgM+ve biliary atresia is a distinct clinical and pathological entity with a diminished response to Kasai portoenterostomy.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Biliary atresia; Cytomegalovirus (CMV); Kasai portoenterostomy; Neonatal cholestatic jaundice

Mesh:

Substances:

Year:  2015        PMID: 25824438     DOI: 10.1016/j.jpedsurg.2015.03.001

Source DB:  PubMed          Journal:  J Pediatr Surg        ISSN: 0022-3468            Impact factor:   2.545


  43 in total

1.  The Canadian Biliary Atresia Registry: Improving the care of Canadian infants with biliary atresia.

Authors:  Alison E Butler; Richard A Schreiber; Natalie Yanchar; Sherif Emil; Jean-Martin Laberge
Journal:  Paediatr Child Health       Date:  2016-04       Impact factor: 2.253

2.  Developmental histology of the portal plate in biliary atresia: observations and implications.

Authors:  Enrico La Pergola; Yoh Zen; Mark Davenport
Journal:  Pediatr Surg Int       Date:  2021-03-01       Impact factor: 1.827

Review 3.  Adjuvant therapy in biliary atresia: hopelessly optimistic or potential for change?

Authors:  Mark Davenport
Journal:  Pediatr Surg Int       Date:  2017-09-22       Impact factor: 1.827

4.  Risk factors and survival outcomes of biliary complications after adult-to-adult living donor liver transplantation.

Authors:  Seogsong Jeong; Xin Wang; Ping Wan; Meng Sha; Jianjun Zhang; Lei Xia; Ying Tong; Yi Luo; Qiang Xia
Journal:  United European Gastroenterol J       Date:  2017-01-18       Impact factor: 4.623

5.  Association of polymorphism in the VEGFA gene 3'-UTR +936T/C with susceptibility to biliary atresia in a Southern Chinese Han population.

Authors:  Fei Liu; Jixiao Zeng; Deli Zhu; Ruizhong Zhang; Xiaogang Xu; Mengmeng Wang; Yan Zhang; Huimin Xia; Zhichun Feng
Journal:  J Clin Lab Anal       Date:  2017-12-18       Impact factor: 2.352

Review 6.  Liver fibrosis in biliary atresia.

Authors:  Wen-Jun Shen; Gong Chen; Min Wang; Shan Zheng
Journal:  World J Pediatr       Date:  2018-11-21       Impact factor: 2.764

7.  Preoperative risk factors for the early failure of the Kasai portoenterostomy in patients with biliary atresia.

Authors:  Mauro Ariel Capparelli; Victor Hugo Ayarzabal; Esteban Tomas Halac; Horacio Alberto Questa; Maria Julia Minetto; Guillermo Cervio; Marcelo Eugenio Barrenechea
Journal:  Pediatr Surg Int       Date:  2021-05-31       Impact factor: 1.827

Review 8.  Sclerosing and obstructive cholangiopathy in biliary atresia: mechanisms and association with biliary innate immunity.

Authors:  Kenichi Harada
Journal:  Pediatr Surg Int       Date:  2017-10-16       Impact factor: 1.827

Review 9.  Update on investigations pertaining to the pathogenesis of biliary atresia.

Authors:  Alexandra Kilgore; Cara L Mack
Journal:  Pediatr Surg Int       Date:  2017-10-24       Impact factor: 1.827

Review 10.  Early and Peri-operative Prognostic Indicators in Infants Undergoing Hepatic Portoenterostomy for Biliary Atresia: a Review.

Authors:  Robert N Lopez; Chee Y Ooi; Usha Krishnan
Journal:  Curr Gastroenterol Rep       Date:  2017-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.